S&P 500
(2.13%) 5 087.82 points
Dow J
(1.13%) 39 048 points
Nasdaq
(3.01%) 16 049 points
Oil
(0.78%) $78.52
Gas
(-2.20%) $1.734
Gold
(-0.06%) $2 033.00
Silver
(-0.34%) $22.80
Platinum
(2.00%) 907.35
USD/EUR
(0.01%) 0.924
USD/NOK
(0.43%) 10.51
USD/GBP
(-0.15%) 0.790
USD/RUB
(1.15%) 93.04

Realtime updates for Ind-Swift Laboratories [INDSWFTLAB.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated22 Feb 2024 @ 04:59

3.81% INR 113.10

Live Chart Being Loaded With Signals

Commentary (22 Feb 2024 @ 04:59):

Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms...

Stats
Today's Volume 677 122
Average Volume 341 462
Market Cap 6.68B
EPS INR0 ( 2024-02-12 )
Last Dividend INR1.000 ( 2011-09-20 )
Next Dividend INR0 ( N/A )
P/E 15.39
ATR14 INR0.196 (0.17%)

Volume Correlation

Long: 0.06 (neutral)
Short: -0.63 (weak negative)
Signal:(53.941) Neutral

Ind-Swift Laboratories Correlation

10 Most Positive Correlations
PVP.NS0.827
ICICIPHARM.NS0.813
KIMS.NS0.811
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ind-Swift Laboratories Correlation - Currency/Commodity

The country flag 0.09
( neutral )
The country flag 0.38
( neutral )
The country flag 0.00
( neutral )
The country flag 0.49
( neutral )
The country flag 0.10
( neutral )
The country flag 0.16
( neutral )

Ind-Swift Laboratories Financials

Annual 2022
Revenue: INR12.07B
Gross Profit: INR5.52B (45.70 %)
EPS: INR8.10
Q3 2023
Revenue: INR2.88B
Gross Profit: INR1.32B (45.94 %)
EPS: INR3.29
Q2 2023
Revenue: INR2.90B
Gross Profit: INR1.45B (50.14 %)
EPS: INR5.36
Q1 2023
Revenue: INR3.10B
Gross Profit: INR1.48B (47.71 %)
EPS: INR2.92

Ind-Swift Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Ind-Swift Laboratories Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.14 - good (71.35%) | Divividend Growth Potential Score: 0.813 - No dividend growth expected in the near future
Information
First Dividend INR1.000 2004-09-23
Last Dividend INR1.000 2011-09-20
Next Dividend INR0 N/A
Payout Date 2011-10-26
Next Payout Date
# dividends 8 --
Total Paid Out INR9.00 --
Avg. Dividend % Per Year 0.00% --
Score 1.77 --
Div. Sustainability Score 7.14
Div.Growth Potential Score 0.813
Div. Directional Score 3.97 --
Next Divdend (Est)
(2024-06-27)
INR0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
1.77
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2004 INR1.000 0.00%
2005 INR1.500 0.00%
2006 INR1.500 0.00%
2007 INR1.000 0.00%
2008 INR1.000 0.00%
2009 INR1.000 0.00%
2010 INR1.000 0.00%
2011 INR1.000 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
REFEX.NS Dividend Knight 2023-09-14 Sporadic 4 0.37%
KSL.NS Dividend Knight 2023-08-11 Sporadic 15 1.81%
FOSECOIND.NS Dividend Knight 2023-05-17 Annually 22 0.68%
ARIHANTSUP.NS Dividend Junior 2023-09-15 Sporadic 8 0.06%
SYRMA.NS Dividend Junior 2023-09-01 Insufficient data to determine frequency 2 0.18%
NIACL.NS No Dividend Player 2023-09-07 Sporadic 7 0.44%
INDOBORAX.NS Dividend Knight 2023-08-11 Annually 3 0.35%
COROMANDEL.NS Dividend Knight 2023-07-13 Annually 19 1.02%
SALZERELEC.NS Dividend Junior 2023-08-24 Sporadic 9 0.58%
MAGADSUGAR.NS Dividend Knight 2023-07-13 Annually 7 1.78%

Ind-Swift Laboratories

Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators